gvtcx

Requirement For Producer Cell Line For GMP Viral Vector Packaging

NHS Blood and Transplant Published 14 Apr 2022 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 33141000
Procedureopen
OCIDocds-h6vhtk-032e03

Award

SupplierValueDateStatus
LIFE TECHNOLOGIES LIMITED · · active

description

NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
14 Apr 2022 Contract award notice (F03) Earlier regulations 010087-2022

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.